Shaohua Tao

机构：Anhui University of Traditional Chinese Medicine, Zhujiang Hospital

发表论文 8 篇 · 总被引 117 次 · h-index 6

代表论文

• Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway (2021 · Acta Pharmacologica Sinica · 被引 35)
• Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections (2015 · International Journal of Neuroscience · 被引 25)
• Discovery of indol-6-yl-pyrrolo[2,3-c]pyridin-7-one derivatives as bromodomain-containing protein 4 (BRD4) inhibitors for the treatment of kidney fibrosis (2022 · European Journal of Medicinal Chemistry · 被引 18)
• Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: A systemic review and meta-analysis (2020 · The International Journal of Biological Markers · 被引 14)
• Lycopene ameliorates Di-(2-ethylhexyl) phthalate-induced neurotoxicity in mice via the gut-brain axis (2025 · Phytomedicine · 被引 10)
• Cardio-selective versus non-selective β-blockers for cardiovascular events and mortality in long-term dialysis patients: A systematic review and meta-analysis (2022 · PLoS ONE · 被引 9)